NCT03697993: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03697993 |
|---|---|
| Title | Multi-center, Randomized, Open-label Trial to Evaluate the Efficacy of Oral Fosfomycin Versus Oral Levofloxacin Strategies in Complicated Urinary Tract Infections (FOCUS) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 7, 2018 |
| Completion date | Oct. 24, 2019 |
| Required reporting date | Oct. 23, 2020, midnight |
| Actual reporting date | Oct. 15, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |